Contraceptives are birth spacing products that aid in avoiding unwanted/ unplanned pregnancy. There are five widely used contraceptive methods namely barrier method, hormonal method, emergency contraception, intrauterine method, and sterilization. Women can opt for wide range of contraceptive options such as vaginal rings, diaphragms, female condoms, oral pills, and intra-uterine devices (IUD). Selecting the most appropriate method is critical to avoid undesired side effects.
Scope of the Report:
This report focuses on the Contraceptives Drugs and Devices in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Contraceptives Drugs and Devices is expected to grow at a CAGR of roughly 8.0% over the next five years, will reach 30100 million US$ in 2023, from 19000 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Teva Pharmaceutical Industries Ltd
- Church & Dwight Co. Inc
- Reckitt Benckiser Plc
- Pfizer, Inc
- Bayer AG
- Mayer Laboratories, Inc
- The Female Health Company
- Cooper Surgical, Inc
- Allergan plc
- Cipla Limited
- Merck & Co. Inc
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives)
- Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)
Market Segment by Applications, can be divided into
- Female
- Male
There are 15 Chapters to deeply display the global Contraceptives Drugs and Devices market.
Chapter 1, to describe Contraceptives Drugs and Devices Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Contraceptives Drugs and Devices, with sales, revenue, and price of Contraceptives Drugs and Devices, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Contraceptives Drugs and Devices, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Contraceptives Drugs and Devices market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Contraceptives Drugs and Devices sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Contraceptives Drugs and Devices Market 2018, Forecast to 2023
Table of Contents
1 Market Overview
1.1 Contraceptives Drugs and Devices Introduction
1.2 Market Analysis by Type
1.2.1 Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives)
1.2.2 Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)
1.3 Market Analysis by Applications
1.3.1 Female
1.3.2 Male
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Teva Pharmaceutical Industries Ltd
2.1.1 Business Overview
2.1.1.1 Teva Pharmaceutical Industries Ltd Description
2.1.1.2 Teva Pharmaceutical Industries Ltd Headquarter, Main Business and Finance Overview
2.1.2 Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Product Introduction
2.1.2.1 Contraceptives Drugs and Devices Production Bases, Sales Regions and Major Competitors
2.1.2.2 Contraceptives Drugs and Devices Product Information
2.1.3 Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Market Share in 2017
2.2 Church & Dwight Co. Inc
2.2.1 Business Overview
2.2.1.1 Church & Dwight Co. Inc Description
2.2.1.2 Church & Dwight Co. Inc Headquarter, Main Business and Finance Overview
2.2.2 Church & Dwight Co. Inc Contraceptives Drugs and Devices Product Introduction
2.2.2.1 Contraceptives Drugs and Devices Production Bases, Sales Regions and Major Competitors
2.2.2.2 Contraceptives Drugs and Devices Product Information
2.2.3 Church & Dwight Co. Inc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Church & Dwight Co. Inc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Church & Dwight Co. Inc Contraceptives Drugs and Devices Market Share in 2017
2.3 Reckitt Benckiser Plc
2.3.1 Business Overview
2.3.1.1 Reckitt Benckiser Plc Description
2.3.1.2 Reckitt Benckiser Plc Headquarter, Main Business and Finance Overview
2.3.2 Reckitt Benckiser Plc Contraceptives Drugs and Devices Product Introduction
2.3.2.1 Contraceptives Drugs and Devices Production Bases, Sales Regions and Major Competitors
2.3.2.2 Contraceptives Drugs and Devices Product Information
2.3.3 Reckitt Benckiser Plc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Reckitt Benckiser Plc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Reckitt Benckiser Plc Contraceptives Drugs and Devices Market Share in 2017
2.4 Pfizer, Inc
2.4.1 Business Overview
2.4.1.1 Pfizer, Inc Description
2.4.1.2 Pfizer, Inc Headquarter, Main Business and Finance Overview
2.4.2 Pfizer, Inc Contraceptives Drugs and Devices Product Introduction
2.4.2.1 Contraceptives Drugs and Devices Production Bases, Sales Regions and Major Competitors
2.4.2.2 Contraceptives Drugs and Devices Product Information
2.4.3 Pfizer, Inc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Pfizer, Inc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Pfizer, Inc Contraceptives Drugs and Devices Market Share in 2017
2.5 Bayer AG
2.5.1 Business Overview
2.5.1.1 Bayer AG Description
2.5.1.2 Bayer AG Headquarter, Main Business and Finance Overview
2.5.2 Bayer AG Contraceptives Drugs and Devices Product Introduction
2.5.2.1 Contraceptives Drugs and Devices Production Bases, Sales Regions and Major Competitors
2.5.2.2 Contraceptives Drugs and Devices Product Information
2.5.3 Bayer AG Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Bayer AG Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Bayer AG Contraceptives Drugs and Devices Market Share in 2017
2.6 Mayer Laboratories, Inc
2.6.1 Business Overview
2.6.1.1 Mayer Laboratories, Inc Description
2.6.1.2 Mayer Laboratories, Inc Headquarter, Main Business and Finance Overview
2.6.2 Mayer Laboratories, Inc Contraceptives Drugs and Devices Product Introduction
2.6.2.1 Contraceptives Drugs and Devices Production Bases, Sales Regions and Major Competitors
2.6.2.2 Contraceptives Drugs and Devices Product Information
2.6.3 Mayer Laboratories, Inc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Mayer Laboratories, Inc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Mayer Laboratories, Inc Contraceptives Drugs and Devices Market Share in 2017
2.7 The Female Health Company
2.7.1 Business Overview
2.7.1.1 The Female Health Company Description
2.7.1.2 The Female Health Company Headquarter, Main Business and Finance Overview
2.7.2 The Female Health Company Contraceptives Drugs and Devices Product Introduction
2.7.2.1 Contraceptives Drugs and Devices Production Bases, Sales Regions and Major Competitors
2.7.2.2 Contraceptives Drugs and Devices Product Information
2.7.3 The Female Health Company Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 The Female Health Company Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global The Female Health Company Contraceptives Drugs and Devices Market Share in 2017
2.8 Cooper Surgical, Inc
2.8.1 Business Overview
2.8.1.1 Cooper Surgical, Inc Description
2.8.1.2 Cooper Surgical, Inc Headquarter, Main Business and Finance Overview
2.8.2 Cooper Surgical, Inc Contraceptives Drugs and Devices Product Introduction
2.8.2.1 Contraceptives Drugs and Devices Production Bases, Sales Regions and Major Competitors
2.8.2.2 Contraceptives Drugs and Devices Product Information
2.8.3 Cooper Surgical, Inc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Cooper Surgical, Inc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Cooper Surgical, Inc Contraceptives Drugs and Devices Market Share in 2017
2.9 Allergan plc
2.9.1 Business Overview
2.9.1.1 Allergan plc Description
2.9.1.2 Allergan plc Headquarter, Main Business and Finance Overview
2.9.2 Allergan plc Contraceptives Drugs and Devices Product Introduction
2.9.2.1 Contraceptives Drugs and Devices Production Bases, Sales Regions and Major Competitors
2.9.2.2 Contraceptives Drugs and Devices Product Information
2.9.3 Allergan plc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 Allergan plc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global Allergan plc Contraceptives Drugs and Devices Market Share in 2017
2.10 Cipla Limited
2.10.1 Business Overview
2.10.1.1 Cipla Limited Description
2.10.1.2 Cipla Limited Headquarter, Main Business and Finance Overview
2.10.2 Cipla Limited Contraceptives Drugs and Devices Product Introduction
2.10.2.1 Contraceptives Drugs and Devices Production Bases, Sales Regions and Major Competitors
2.10.2.2 Contraceptives Drugs and Devices Product Information
2.10.3 Cipla Limited Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 Cipla Limited Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global Cipla Limited Contraceptives Drugs and Devices Market Share in 2017
2.11 Merck & Co. Inc
2.11.1 Business Overview
2.11.2 Merck & Co. Inc Contraceptives Drugs and Devices Product Introduction
2.11.3 Merck & Co. Inc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Contraceptives Drugs and Devices Market Competition, by Manufacturer
3.1 Global Contraceptives Drugs and Devices Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Contraceptives Drugs and Devices Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Contraceptives Drugs and Devices Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Contraceptives Drugs and Devices Manufacturer Market Share in 2017
3.4.2 Top 5 Contraceptives Drugs and Devices Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Contraceptives Drugs and Devices Market Analysis by Regions
4.1 Global Contraceptives Drugs and Devices Sales, Revenue and Market Share by Regions
4.1.1 Global Contraceptives Drugs and Devices Sales by Regions (2013-2018)
4.1.2 Global Contraceptives Drugs and Devices Revenue by Regions (2013-2018)
4.2 North America Contraceptives Drugs and Devices Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Contraceptives Drugs and Devices Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Contraceptives Drugs and Devices Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Contraceptives Drugs and Devices Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Contraceptives Drugs and Devices Sales, Revenue and Growth Rate (2013-2018)
5 North America Contraceptives Drugs and Devices by Countries, Type, Application and Manufacturers
5.1 North America Contraceptives Drugs and Devices Sales, Revenue and Market Share by Countries
5.1.1 North America Contraceptives Drugs and Devices Sales by Countries (2013-2018)
5.1.2 North America Contraceptives Drugs and Devices Revenue by Countries (2013-2018)
5.1.3 United States Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
5.1.4 Canada Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
5.1.5 Mexico Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
5.2 North America Contraceptives Drugs and Devices Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Contraceptives Drugs and Devices Sales by Manufacturers (2016-2017)
5.2.2 North America Contraceptives Drugs and Devices Revenue by Manufacturers (2016-2017)
5.3 North America Contraceptives Drugs and Devices Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Contraceptives Drugs and Devices Sales and Sales Share by Type (2013-2018)
5.3.2 North America Contraceptives Drugs and Devices Revenue and Revenue Share by Type (2013-2018)
5.4 North America Contraceptives Drugs and Devices Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Contraceptives Drugs and Devices Sales and Sales Share by Application (2013-2018)
5.4.2 North America Contraceptives Drugs and Devices Revenue and Revenue Share by Application (2013-2018)
6 Europe Contraceptives Drugs and Devices by Countries, Type, Application and Manufacturers
6.1 Europe Contraceptives Drugs and Devices Sales, Revenue and Market Share by Countries
6.1.1 Europe Contraceptives Drugs and Devices Sales by Countries (2013-2018)
6.1.2 Europe Contraceptives Drugs and Devices Revenue by Countries (2013-2018)
6.1.3 Germany Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
6.1.4 UK Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
6.1.5 France Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
6.1.6 Russia Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
6.1.7 Italy Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
6.2 Europe Contraceptives Drugs and Devices Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Contraceptives Drugs and Devices Sales by Manufacturers (2016-2017)
6.2.2 Europe Contraceptives Drugs and Devices Revenue by Manufacturers (2016-2017)
6.3 Europe Contraceptives Drugs and Devices Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Contraceptives Drugs and Devices Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Contraceptives Drugs and Devices Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Contraceptives Drugs and Devices Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Contraceptives Drugs and Devices Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Contraceptives Drugs and Devices Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Contraceptives Drugs and Devices by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Contraceptives Drugs and Devices Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Contraceptives Drugs and Devices Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Contraceptives Drugs and Devices Revenue by Countries (2013-2018)
7.1.3 China Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
7.1.4 Japan Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
7.1.5 Korea Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
7.1.6 India Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Contraceptives Drugs and Devices Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Contraceptives Drugs and Devices Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Contraceptives Drugs and Devices Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Contraceptives Drugs and Devices Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Contraceptives Drugs and Devices Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Contraceptives Drugs and Devices Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Contraceptives Drugs and Devices Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Contraceptives Drugs and Devices Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Contraceptives Drugs and Devices Revenue and Revenue Share by Application (2013-2018)
8 South America Contraceptives Drugs and Devices by Countries, Type, Application and Manufacturers
8.1 South America Contraceptives Drugs and Devices Sales, Revenue and Market Share by Countries
8.1.1 South America Contraceptives Drugs and Devices Sales by Countries (2013-2018)
8.1.2 South America Contraceptives Drugs and Devices Revenue by Countries (2013-2018)
8.1.3 Brazil Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
8.1.4 Argentina Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
8.1.5 Colombia Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
8.2 South America Contraceptives Drugs and Devices Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Contraceptives Drugs and Devices Sales by Manufacturers (2016-2017)
8.2.2 South America Contraceptives Drugs and Devices Revenue by Manufacturers (2016-2017)
8.3 South America Contraceptives Drugs and Devices Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Contraceptives Drugs and Devices Sales and Sales Share by Type (2013-2018)
8.3.2 South America Contraceptives Drugs and Devices Revenue and Revenue Share by Type (2013-2018)
8.4 South America Contraceptives Drugs and Devices Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Contraceptives Drugs and Devices Sales and Sales Share by Application (2013-2018)
8.4.2 South America Contraceptives Drugs and Devices Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Contraceptives Drugs and Devices by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Contraceptives Drugs and Devices Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Contraceptives Drugs and Devices Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Contraceptives Drugs and Devices Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
9.1.4 UAE Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
9.1.5 Egypt Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
9.1.7 South Africa Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Contraceptives Drugs and Devices Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Contraceptives Drugs and Devices Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Contraceptives Drugs and Devices Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Contraceptives Drugs and Devices Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Contraceptives Drugs and Devices Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Contraceptives Drugs and Devices Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Contraceptives Drugs and Devices Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Contraceptives Drugs and Devices Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Contraceptives Drugs and Devices Revenue and Revenue Share by Application (2013-2018)
10 Global Contraceptives Drugs and Devices Market Segment by Type
10.1 Global Contraceptives Drugs and Devices Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Contraceptives Drugs and Devices Sales and Market Share by Type (2013-2018)
10.1.2 Global Contraceptives Drugs and Devices Revenue and Market Share by Type (2013-2018)
10.2 Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives) Sales Growth and Price
10.2.1 Global Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives) Sales Growth (2013-2018)
10.2.2 Global Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives) Price (2013-2018)
10.3 Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices) Sales Growth and Price
10.3.1 Global Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices) Sales Growth (2013-2018)
10.3.2 Global Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices) Price (2013-2018)
11 Global Contraceptives Drugs and Devices Market Segment by Application
11.1 Global Contraceptives Drugs and Devices Sales Market Share by Application (2013-2018)
11.2 Female Sales Growth (2013-2018)
11.3 Male Sales Growth (2013-2018)
12 Contraceptives Drugs and Devices Market Forecast (2018-2023)
12.1 Global Contraceptives Drugs and Devices Sales, Revenue and Growth Rate (2018-2023)
12.2 Contraceptives Drugs and Devices Market Forecast by Regions (2018-2023)
12.2.1 North America Contraceptives Drugs and Devices Market Forecast (2018-2023)
12.2.2 Europe Contraceptives Drugs and Devices Market Forecast (2018-2023)
12.2.3 Asia-Pacific Contraceptives Drugs and Devices Market Forecast (2018-2023)
12.2.4 South America Contraceptives Drugs and Devices Market Forecast (2018-2023)
12.2.5 Middle East and Africa Contraceptives Drugs and Devices Market Forecast (2018-2023)
12.3 Contraceptives Drugs and Devices Market Forecast by Type (2018-2023)
12.3.1 Global Contraceptives Drugs and Devices Sales Forecast by Type (2018-2023)
12.3.2 Global Contraceptives Drugs and Devices Market Share Forecast by Type (2018-2023)
12.4 Contraceptives Drugs and Devices Market Forecast by Application (2018-2023)
12.4.1 Global Contraceptives Drugs and Devices Sales Forecast by Application (2018-2023)
12.4.2 Global Contraceptives Drugs and Devices Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Contraceptives Drugs and Devices Picture
Table Product Specifications of Contraceptives Drugs and Devices
Figure Global Contraceptives Drugs and Devices CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Contraceptives Drugs and Devices CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Contraceptives Drugs and Devices by Types in 2017
Figure Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives) Picture
Table Major Manufacturers of Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives)
Figure Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices) Picture
Table Major Manufacturers of Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)
Figure Contraceptives Drugs and Devices Sales Market Share by Applications in 2017
Figure Female Picture
Figure Male Picture
Figure United States Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2013-2023)
Figure France Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2013-2023)
Figure UK Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2013-2023)
Figure China Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2013-2023)
Figure India Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2013-2023)
Table Teva Pharmaceutical Industries Ltd Headquarter, Established, Main Business and Finance Overview (2017)
Table Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Production Bases, Sales Regions and Major Competitors
Table Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Product
Table Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Sales Market Share in 2017
Figure Global Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Revenue Market Share in 2017
Table Church & Dwight Co. Inc Headquarter, Established, Main Business and Finance Overview (2017)
Table Church & Dwight Co. Inc Contraceptives Drugs and Devices Production Bases, Sales Regions and Major Competitors
Table Church & Dwight Co. Inc Contraceptives Drugs and Devices Product
Table Church & Dwight Co. Inc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Church & Dwight Co. Inc Contraceptives Drugs and Devices Sales Market Share in 2017
Figure Global Church & Dwight Co. Inc Contraceptives Drugs and Devices Revenue Market Share in 2017
Table Reckitt Benckiser Plc Headquarter, Established, Main Business and Finance Overview (2017)
Table Reckitt Benckiser Plc Contraceptives Drugs and Devices Production Bases, Sales Regions and Major Competitors
Table Reckitt Benckiser Plc Contraceptives Drugs and Devices Product
Table Reckitt Benckiser Plc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Reckitt Benckiser Plc Contraceptives Drugs and Devices Sales Market Share in 2017
Figure Global Reckitt Benckiser Plc Contraceptives Drugs and Devices Revenue Market Share in 2017
Table Pfizer, Inc Headquarter, Established, Main Business and Finance Overview (2017)
Table Pfizer, Inc Contraceptives Drugs and Devices Production Bases, Sales Regions and Major Competitors
Table Pfizer, Inc Contraceptives Drugs and Devices Product
Table Pfizer, Inc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Pfizer, Inc Contraceptives Drugs and Devices Sales Market Share in 2017
Figure Global Pfizer, Inc Contraceptives Drugs and Devices Revenue Market Share in 2017
Table Bayer AG Headquarter, Established, Main Business and Finance Overview (2017)
Table Bayer AG Contraceptives Drugs and Devices Production Bases, Sales Regions and Major Competitors
Table Bayer AG Contraceptives Drugs and Devices Product
Table Bayer AG Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Bayer AG Contraceptives Drugs and Devices Sales Market Share in 2017
Figure Global Bayer AG Contraceptives Drugs and Devices Revenue Market Share in 2017
Table Mayer Laboratories, Inc Headquarter, Established, Main Business and Finance Overview (2017)
Table Mayer Laboratories, Inc Contraceptives Drugs and Devices Production Bases, Sales Regions and Major Competitors
Table Mayer Laboratories, Inc Contraceptives Drugs and Devices Product
Table Mayer Laboratories, Inc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Mayer Laboratories, Inc Contraceptives Drugs and Devices Sales Market Share in 2017
Figure Global Mayer Laboratories, Inc Contraceptives Drugs and Devices Revenue Market Share in 2017
Table The Female Health Company Headquarter, Established, Main Business and Finance Overview (2017)
Table The Female Health Company Contraceptives Drugs and Devices Production Bases, Sales Regions and Major Competitors
Table The Female Health Company Contraceptives Drugs and Devices Product
Table The Female Health Company Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global The Female Health Company Contraceptives Drugs and Devices Sales Market Share in 2017
Figure Global The Female Health Company Contraceptives Drugs and Devices Revenue Market Share in 2017
Table Cooper Surgical, Inc Headquarter, Established, Main Business and Finance Overview (2017)
Table Cooper Surgical, Inc Contraceptives Drugs and Devices Production Bases, Sales Regions and Major Competitors
Table Cooper Surgical, Inc Contraceptives Drugs and Devices Product
Table Cooper Surgical, Inc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Cooper Surgical, Inc Contraceptives Drugs and Devices Sales Market Share in 2017
Figure Global Cooper Surgical, Inc Contraceptives Drugs and Devices Revenue Market Share in 2017
Table Allergan plc Headquarter, Established, Main Business and Finance Overview (2017)
Table Allergan plc Contraceptives Drugs and Devices Production Bases, Sales Regions and Major Competitors
Table Allergan plc Contraceptives Drugs and Devices Product
Table Allergan plc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Allergan plc Contraceptives Drugs and Devices Sales Market Share in 2017
Figure Global Allergan plc Contraceptives Drugs and Devices Revenue Market Share in 2017
Table Cipla Limited Headquarter, Established, Main Business and Finance Overview (2017)
Table Cipla Limited Contraceptives Drugs and Devices Production Bases, Sales Regions and Major Competitors
Table Cipla Limited Contraceptives Drugs and Devices Product
Table Cipla Limited Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Cipla Limited Contraceptives Drugs and Devices Sales Market Share in 2017
Figure Global Cipla Limited Contraceptives Drugs and Devices Revenue Market Share in 2017
Table Merck & Co. Inc
Table Merck & Co. Inc Contraceptives Drugs and Devices
Table Global Contraceptives Drugs and Devices Sales by Manufacturer (2016-2017)
Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
Published: 11-Jan-2024 Price: US 3350 Onwards Pages: 118
The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029.
Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029.
Report Scope
This report aims to provide a comprehensive presentation of the glo......
Global Non-imaging Diagnostic Catheter Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 95
The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
Global Imaging Diagnostic Catheter Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 90
The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
Global PCR Equipment Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 77
The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030.
PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers:
Advancements in Research and Diagnost......
Global Disposable Sterile Syringes and Needles Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 109
The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030.
North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Disposable Sterile Syringes and N......
Global Orthopaedic Power Tools Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 106
The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030.
North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
Global Cerebrospinal Fluid Management Devices Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
Global CAD & CAM Milling Burs Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 79
The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
Global Artificial Teeth Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 98
The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
